Emerging Therapy, Unmet Needs and TPP Insights

Connect with Expert

Thelansis’s “Emerging Therapy Insights” report provides a comprehensive analysis of the emerging competitive landscape, unmet needs, target product profiles (TPPs), trial designs, and KOL insights on key emerging therapies and key drug development opportunities in the indication.

Key outcomes:

  • What are the emerging therapies under development for the specific disease area in the G8 markets (US, EU5, Japan, China)?
  • What are the target patient groups and the analysis of clinical trials’ design?
  • What are the key primary and secondary endpoints, and expectations of KOLs from the therapies?
  • What is the probability of success for emerging therapies?
  • What are KOL expectations from emerging therapies to overcome the challenges of current therapies?
  • What would be the market share for studied TPPs for the specific disease area?

Reports:

October 31, 2024

Market Outlook and Forecast

Iron Deficiency Anemia (IDA) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034

Thelansis’s “Iron Deficiency Anemia (IDA) Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034″ covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Iron Deficiency Anemia treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China).

October 16, 2024

Market Outlook and Forecast

Pulmonary Hypertension associated with Interstitial Lung Disease (PH-ILD) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034

Thelansis’s “Pulmonary Hypertension associated with Interstitial Lung Disease (PH-ILD) Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034″ covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Pulmonary Hypertension associated with Interstitial Lung Disease treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China).

October 22, 2024

Market Outlook and Forecast

Glycogen Storage Disease Type 1a (GSD1a) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034

Thelansis’s “Glycogen Storage Disease Type 1a (GSD1a) Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034″ covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Glycogen Storage Disease Type 1a treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China).

October 11, 2024

Market Outlook and Forecast

Severe Aplastic Anemia (SAA) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034

Thelansis’s “Severe Aplastic Anemia (SAA) Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034″ covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Severe Aplastic Anemia treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China).

October 27, 2024

Market Outlook and Forecast

Iron Overload Syndrome – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034

Thelansis’s “Iron Overload Syndrome Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034″ covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Iron Overload Syndrome treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China).

October 20, 2024

Market Outlook and Forecast

Postoperative Nausea and Vomiting (PONV) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034

Thelansis’s “Postoperative Nausea and Vomiting (PONV) Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034″ covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Postoperative Nausea and Vomiting treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China).

Explore Reports

Need customize support?

Thelansis also caters to your specific needs by providing customized reports that satisfy your organizational requirements. Get on-demand customization of the report’s scope to exactly meet your needs.

Connect with Expert